🏛️ Verified NIH Record • Updated 2026-06-25

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) (NCT07327489)

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Elephas

🩺 Plain-English Summary (8th-Grade Level)

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (4 items).

Location: Mercy Hospital - FTS — Fort Smith, Arkansas

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Have a known auto-immune disease or prior condition (prior organ transplant, chronic kidney or liver disease) that renders them ineligible for immunotherapy (IO) treatment.
  • Severely immunocompromised person(s). Examples include patients on immunosuppressants, HIV positive patients on antiretrovirals, post transplantation patients.
  • Pregnant person(s).

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (8 Sites)

  • Mercy Hospital - FTS — Fort Smith, Arkansas
  • Frederick Health Hospital — Frederick, Maryland
  • Mercy Hospital - SPG — Springfield, Missouri
  • Mercy Hospital - South — St Louis, Missouri
  • Mercy Hospital -STL — St Louis, Missouri
  • Mercy Hospital - OKC — Oklahoma City, Oklahoma
  • JPS Health Network — Forth Worth, Texas
  • Baylor Scott and White Biorepository — Temple, Texas

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗